The Environmental Impact of Fluorinated Gas in Retina Surgery

Reducing reliance on fluorinated gases could make retina care more environmentally sustainable.

By Scott M. McClintic, MD, Jacob D. Grodsky, MD, Geoffrey G. Emerson, MD, PhD, FASRS

Best Practices for Clinical Research Site Collaboration

How to avoid an FDA warning letter.

By Thomas A. Ciulla, MD, MBA

Investigational TKIs for Retinal Exudative Diseases

Vorolanib, axitinib, and migaldendranib may offer sustained and targeted therapy for nAMD and DME.

By Priya Vakharia, MD

Placing Argentina on the Clinical Trials Map

Improved research facilities and collaborative networks are establishing the country as a reliable partner for global ophthalmology studies.

By Patricio G. Schlottmann, MD

Practice Management for Photobiomodulation of the Retina

Coding, billing, and reimbursement for a novel treatment for dry AMD.

By Kevin J. Corcoran, COE, FNAO

Thankful

Upfront: This issue features articles on clinical trials and practice management.

By Diana V. Do, MD

What to Look for in a Retina Fellowship

Early Career Perspectives in Retina: Not all programs are the same—here’s how to find the one that fits your goals and personality.

By Jonathan B. Lin, MD, PhD

Documentation Errors, Compliance Consequences

Coding: By aligning documentation, workflows, and staff training, retina practices can minimize denials, reduce audit risk, and maintain a smooth operation.

By Elizabeth Cifers, MBA, MSW, CHC, CPC

Clinical Trial Update November/December 2025

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Home OCT and Modeling May Reduce Trial Sizes

Home OCT with PK/PD modeling achieved the same power as traditional biweekly, on-site monitoring with only 33 to 35 patients per arm

By Sarah Fackler, staff writer

Tracking Reflectivity Metrics in CSCR

Structural integrity of the ellipsoid zone before therapy could predict treatment outcomes.

By Sarah Fackler, staff writer

Implant Restores Central Vision in GA 

Results from the PRIMAvera trial on the photovoltaic retina implant microarray (PRIMA) system

By Sarah Fackler, staff writer

Study Finds CME Prevalence in RP is Gene-Dependent

Development of cystoid macular edema was most strongly associated with mutations in genes that encode splicing factors.

By Sarah Fackler, staff writer

Four-Mechanism Gene Therapy Shows Slower GA Lesion Growth

The phase 1/2 study also showed no serious adverse events

By Jay Chhablani, MD, Michael A. Singer, MD

Industry Insights: Inventory to Impact

What retina leaders want from their GPO and Specialty Distributor